Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Novartis researchers are using data to accelerate drug development.

Deep in a forest in the West African country of Ghana, two men are searching for plants that they hope could ultimately provide a cure for some of the world’s deadliest diseases.

An immunologist shares tips from a team-based environment

Researchers around the world are collaborating to provide solutions to immediate and future challenges.

Zebrafish imaging sheds light on human neurological conditions.

Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.

The most lethal strain could be eliminated by 2030, but major hurdles remain.

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.